Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

biogen_austria_238

Biogen fails to meet primary endpoint in XLRP study

May 17, 2021 Sales and Marketing Biogen, Clinical Trail

Biogen have released topline results from its Phase2/3 Xirius study of cotoretigene toliparvovec (BIIB112) as a gene therapy for patients …
News

Self-administered Crysvita receives positive CHMP opinion

May 10, 2021 Sales and Marketing CHMP, EMA

Kyowa Kirin’s drug for a rare metabolic bone disease, Crysvita, has received a positive opinion from the EMA’s Committee for …
News

NICE rejects Merck Serono’s Bavencio for urothelial cancer

May 10, 2021 Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news

The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
News
GSK building

EMA begin review of GSK & Vir COVID-19 treatment

May 10, 2021 Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
News
Pfizer sign

Pfizer commences process for full FDA approval of COVID-19 vaccine

May 10, 2021 Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news

Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …
News
lilly_entrance_web

Eli Lilly to collaborate with diabetes tech companies on insulin pen

May 10, 2021 Sales and Marketing Eli Lilly, diabetes

Eli Lilly has signed strategic international agreements with four companies – Dexcom, Glooko, myDiabby Healthcare, and Roche – with the …
News

NICE finds more SMA patients eligible for £75,000 a vial drug

May 4, 2021 Manufacturing and Production, Sales and Marketing NICE, sma

NICE has announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen, …
News

Needle-free pandemic influenza vaccine sees preclinical proof-of-concept

May 4, 2021 Manufacturing and Production, Sales and Marketing Vaccine technology

Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …
News
moderna_norwood_plant

Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021 Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …
News
download_2

Sheila Frame new President for the Americas at Amryt

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.
Appointment
download_1

Francesco Maria Lavino appointed CEO of F2G Ltd

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …
Appointment
download

Macrogen Europe appoints Dr Bongcho Kim as new CEO

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …
Appointment

King & Spalding announce appointment of former FDA official

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …
Appointment

Are we on the cusp of an AI revolution?

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Feature

Navigating through the post-COVID-19 R&D bottleneck

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Jack Goddard inve
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026